{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:35:29Z","timestamp":1787016929116,"version":"build-2736575974"},"reference-count":55,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"unspecified","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,6,10]]},"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess compliance with statutory requirements to register and report outcomes in interventional trials of mesenchymal stromal cells (MSCs) for musculoskeletal disorders and to describe the trials\u2019 clinical and design characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A systematic review of published trials and trials submitted to public registries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>The databases Medline, Cochrane Library and McMaster; six public clinical registries. All searches were done until 31 January 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Eligibility criteria<\/jats:title>\n                    <jats:p>Trials submitted to registries and completed before January 2021. Prospective interventional trials published in peer-reviewed journals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data extraction and synthesis<\/jats:title>\n                    <jats:p>The first author searched for trials that had (1) posted trial results in a public registry, (2) presented results in a peer-reviewed publication and (3) submitted a pretrial protocol to a registry before publication. Other extracted variables included trial design, number of participants, funding source, follow-up duration and cell type.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In total 124 trials were found in registries and literature databases. Knee osteoarthritis was the most common indication. Of the 100 registry trials, 52 trials with in total 2 993 participants had neither posted results in the registry nor published results. Fifty-two of the registry trials submitted a protocol retrospectively. Forty-three of the 67 published trials (64%) had registered a pretrial protocol. Funding source was not associated with compliance with reporting requirements. A discrepancy between primary endpoints in the registry and publication was found in 16 of 25 trials. In 28% of trials, the treatment groups used adjuvant therapies. Only 39% of controlled trials were double-blinded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A large proportion of trials failed to comply with statutory requirements for the registration and reporting of results, thereby increasing the risk of bias in outcome assessments. To improve confidence in the role of MSCs for musculoskeletal disorders, registries and medical journals should more rigorously enforce existing requirements for registration and reporting.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-081343","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T02:52:35Z","timestamp":1719370355000},"page":"e081343","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Compliance with requirements for registration and reporting of results in trials of mesenchymal stromal cells for musculoskeletal disorders: a systematic review"],"prefix":"10.1136","volume":"14","clinical-trial-number":[{"clinical-trial-number":"nct01953523","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8436-4519","authenticated-orcid":false,"given":"Robin","family":"Holtedahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2507-1812","authenticated-orcid":false,"given":"Jens Ivar","family":"Brox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,6,25]]},"reference":[{"key":"2024082721105793000_14.6.e081343.1","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2638305","article-title":"The Holy Grail of orthopedic surgery: Mesenchymal stem cells - their current uses and potential applications","volume":"2017","author":"Berebichez-Fridman","year":"2017","journal-title":"Stem Cells Int"},{"key":"2024082721105793000_14.6.e081343.2","first-page":"1","article-title":"Current perspectives in stem cell research for knee cartilage repair","volume":"7","author":"Orth","year":"2014","journal-title":"Stem Cells Cloning"},{"key":"2024082721105793000_14.6.e081343.3","doi-asserted-by":"crossref","DOI":"10.1186\/s13018-017-0534-y","article-title":"The use of Mesenchymal stem cells for cartilage repair and regeneration: A systematic review","volume":"12","author":"Goldberg","year":"2017","journal-title":"J Orthop Surg Res"},{"key":"2024082721105793000_14.6.e081343.4","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00167-022-07063-7","article-title":"Cell-based therapies have disease-modifying effects on osteoarthritis in animal models. A systematic review by the ESSKA Orthobiologic initiative. part 1: Adipose tissue-derived cell-based Injectable therapies","volume":"31","author":"Perucca Orfei","year":"2023","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"2024082721105793000_14.6.e081343.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2013.02.006"},{"key":"2024082721105793000_14.6.e081343.6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/scrt214","article-title":"Immunoregulatory properties of clinical grade Mesenchymal Stromal cells: evidence, uncertainties, and clinical application","volume":"4","author":"M\u00e9nard","year":"2013","journal-title":"Stem Cell Res Ther"},{"key":"2024082721105793000_14.6.e081343.7","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.2005-0342"},{"key":"2024082721105793000_14.6.e081343.8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.arthro.2018.05.037","article-title":"The clinical evidence behind biologic therapies promoted at annual Orthopaedic meetings: A systematic review","volume":"35","author":"Hadley","year":"2019","journal-title":"Arthroscopy: J Arthroscopic Related Surg"},{"key":"2024082721105793000_14.6.e081343.9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.22203\/eCM.v043a09","article-title":"Controversies in Regenerative medicine: should knee joint osteoarthritis be treated with Mesenchymal Stromal cells","volume":"43","author":"Ossendorff","year":"2022","journal-title":"Eur Cell Mater"},{"key":"2024082721105793000_14.6.e081343.10","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3826054","article-title":"Meta-analysis and evidence base for the efficacy of Autologous bone marrow Mesenchymal stem cells in knee cartilage repair: methodological guidelines and quality assessment","volume":"2019","author":"Awad","year":"2019","journal-title":"Stem Cells Int"},{"key":"2024082721105793000_14.6.e081343.11","doi-asserted-by":"publisher","DOI":"10.1007\/s00402-020-03703-0"},{"key":"2024082721105793000_14.6.e081343.12","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41423-023-01020-1","article-title":"Culture-expanded Mesenchymal Stromal cell therapy: does it work in knee osteoarthritis? A pathway to clinical success","volume":"20","author":"Copp","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"2024082721105793000_14.6.e081343.13","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-022-02953-0","article-title":"Intra-Articular injection choice for osteoarthritis: making sense of cell source\u2014an updated systematic review and dual network meta-analysis","volume":"24","author":"Zhang","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"2024082721105793000_14.6.e081343.14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2106\/JBJS.17.01474","article-title":"Nomenclature inconsistency and selective outcome reporting hinder understanding of stem cell therapy for the knee","volume":"101","author":"Jones","year":"2019","journal-title":"J Bone Joint Surg Am"},{"key":"2024082721105793000_14.6.e081343.15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.arthro.2018.08.027","article-title":"Editorial commentary: stem cell treatment for knee osteoarthritis: holy Grail or tin cup","volume":"35","author":"Getelman","year":"2019","journal-title":"Arthroscopy"},{"key":"2024082721105793000_14.6.e081343.16","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X221117879","article-title":"Stromal vascular fraction therapy for knee osteoarthritis: a systematic review","volume":"14","author":"Boada-Pladellorens","year":"2022","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2024082721105793000_14.6.e081343.17","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.arthro.2020.05.037","article-title":"Regenerative potential of Mesenchymal stem cells for the treatment of knee osteoarthritis and Chondral defects: A systematic review and meta-analysis","volume":"37","author":"Maheshwer","year":"2021","journal-title":"Arthroscopy"},{"key":"2024082721105793000_14.6.e081343.18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta4100","article-title":"Publication and related biases","volume":"4","author":"Song","year":"2000","journal-title":"Health Technol Assess"},{"key":"2024082721105793000_14.6.e081343.19","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e318299d00b"},{"key":"2024082721105793000_14.6.e081343.20","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.2217\/cer-2019-0068","article-title":"Selective reporting bias due to discrepancies between registered and published outcomes in osteoarthritis trials","volume":"8","author":"Krsticevic","year":"2019","journal-title":"J Comp Eff Res"},{"key":"2024082721105793000_14.6.e081343.21","doi-asserted-by":"crossref","unstructured":"Hopewell S , Loudon K , Clarke MJ , et al . Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database Syst Rev 2009;2009. doi:10.1002\/14651858.MR000006.pub3","DOI":"10.1002\/14651858.MR000006.pub3"},{"key":"2024082721105793000_14.6.e081343.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1012065"},{"key":"2024082721105793000_14.6.e081343.23","unstructured":"Food and Drug Administration . n.d. Food and Drug Administration amendments act of 2007. public law No.110-85 \u00a7 801."},{"key":"2024082721105793000_14.6.e081343.24","unstructured":"Commission Guideline . n.d. Guidance on posting and publication of result-related information on clinical trials in relation to the implementation of article 57(2) of regulation (EC) no 726\/2004 and article 41(2) of regulation (EC) no 1901\/2006."},{"key":"2024082721105793000_14.6.e081343.25","unstructured":"WHO . Joint statement on public disclosure of results from clinical trials. n.d. Available: https:\/\/www.who.int\/news\/item\/18-05-2017-joint-statement-on-registration"},{"key":"2024082721105793000_14.6.e081343.26","unstructured":"International Committee of Medical Journal Editors . Clinical trials. n.d. Available: https:\/\/www.icmje.org\/recommendations\/browse\/publishing-and-editorial-issues\/clinical-trial-registration.html"},{"key":"2024082721105793000_14.6.e081343.27","unstructured":"Rasko J , Power C . Flesh Made New: The Unnatural History and Broken Promise of Stem Cells. 195 Broadway. New York, NY: Harper Collins Publishing Company, 2021:460\u2013276."},{"key":"2024082721105793000_14.6.e081343.28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"2024082721105793000_14.6.e081343.29","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.20.2457"},{"key":"2024082721105793000_14.6.e081343.30","doi-asserted-by":"crossref","first-page":"185S","DOI":"10.1177\/1947603520906597","article-title":"\u201cThe long-lasting effects of \u201cplacebo injections\u201d in knee osteoarthritis: A meta-analysis\u201d","volume":"13","author":"Previtali","year":"2021","journal-title":"Cartilage"},{"key":"2024082721105793000_14.6.e081343.31","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.arthro.2020.10.016","article-title":"Intra-Articular Mesenchymal Stromal cell injections are no different from placebo in the treatment of knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials","volume":"37","author":"Dai","year":"2021","journal-title":"Arthroscopy"},{"key":"2024082721105793000_14.6.e081343.32","unstructured":"Federal Register . Clinical trials registration and results information submission. n.d. Available: https:\/\/www.federalregister.gov\/"},{"key":"2024082721105793000_14.6.e081343.33","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.15.00400"},{"key":"2024082721105793000_14.6.e081343.34","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-022-06569-2","article-title":"Update on the clinical trial landscape: analysis of Clinicaltrials.Gov registration data, 2000\u20132020","volume":"23","author":"Gresham","year":"2022","journal-title":"Trials"},{"key":"2024082721105793000_14.6.e081343.35","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-016-0551-4","article-title":"Public availability of results of observational studies evaluating an intervention registered at Clinicaltrials.Gov","volume":"14","author":"Baudart","year":"2016","journal-title":"BMC Med"},{"key":"2024082721105793000_14.6.e081343.36","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)33220-9"},{"key":"2024082721105793000_14.6.e081343.37","doi-asserted-by":"crossref","unstructured":"Goldacre B , DeVito NJ , Heneghan C , et al . Compliance with requirement to report results on the EU clinical trials register: cohort study and web resource. BMJ 2018;k3218. doi:10.1136\/bmj.k3218","DOI":"10.1136\/bmj.k3218"},{"key":"2024082721105793000_14.6.e081343.38","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m982","article-title":"Prospective registration and reporting of trial number in randomised clinical trials: global cross sectional study of the adoption of ICMJE and declaration of Helsinki recommendations","volume":"369","author":"Al-Durra","year":"2020","journal-title":"BMJ"},{"key":"2024082721105793000_14.6.e081343.39","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1302\/0301-620X.102B2.BJJ-2019-1104.R1","article-title":"Rogue stem cell clinics","volume":"102-B","author":"Murray","year":"2020","journal-title":"Bone Joint J"},{"key":"2024082721105793000_14.6.e081343.40","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2106\/JBJS.19.00714","article-title":"Online direct-to-consumer advertising of stem cell therapy for musculoskeletal injury and disease","volume":"102","author":"Kingery","year":"2020","journal-title":"J Bone Joint Surg"},{"key":"2024082721105793000_14.6.e081343.41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2217\/rme-2017-0115","article-title":"The FDA and the US direct-to-consumer marketplace for stem cell interventions: A temporal analysis","volume":"13","author":"Knoepfler","year":"2018","journal-title":"Regen Med"},{"key":"2024082721105793000_14.6.e081343.42","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aai7514"},{"key":"2024082721105793000_14.6.e081343.43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1716145"},{"key":"2024082721105793000_14.6.e081343.44","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.stemcr.2016.05.001","article-title":"Setting global standards for stem cell research and clinical translation: the 2016 ISSCR guidelines","volume":"6","author":"Daley","year":"2016","journal-title":"Stem Cell Reports"},{"key":"2024082721105793000_14.6.e081343.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2019.06.011"},{"key":"2024082721105793000_14.6.e081343.46","unstructured":"The International Society for Stem Cell Research . Clinical translation of stem cell-based interventions. n.d. Available: https:\/\/www.isscr.org\/guidelines\/blog-post-title-one-ed2td-6fcdk-5zr5l"},{"key":"2024082721105793000_14.6.e081343.47","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.arth.2018.12.001","article-title":"Biologic therapies for the treatment of knee osteoarthritis","volume":"34","author":"Delanois","year":"2019","journal-title":"J Arthroplasty"},{"key":"2024082721105793000_14.6.e081343.48","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ocl.2019.06.001","article-title":"The current status of cell-based therapies for primary knee osteoarthritis","volume":"50","author":"Vakharia","year":"2019","journal-title":"Orthop Clin North Am"},{"key":"2024082721105793000_14.6.e081343.49","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1007\/s00167-018-4955-x","article-title":"Limited evidence for Adipose-derived stem cell therapy on the treatment of osteoarthritis","volume":"26","author":"Hurley","year":"2018","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"2024082721105793000_14.6.e081343.50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm9072062","article-title":"Mesenchymal Stromal cell-based therapy\u2014an alternative to Arthroplasty for the treatment of osteoarthritis? A state of the art review of clinical trials","volume":"9","author":"Maleitzke","year":"2020","journal-title":"J Clin Med"},{"key":"2024082721105793000_14.6.e081343.51","doi-asserted-by":"crossref","DOI":"10.3390\/cells11060965","article-title":"Methodological flaws in meta-analyses of clinical studies on the management of knee osteoarthritis with stem cells: A systematic review","volume":"11","author":"Schmitz","year":"2022","journal-title":"Cells"},{"key":"2024082721105793000_14.6.e081343.52","doi-asserted-by":"crossref","first-page":"104S","DOI":"10.1177\/1947603520942947","article-title":"Efficacy and safety of intra-Articular cell-based therapy for osteoarthritis: systematic review and network meta-analysis","volume":"13","author":"Ding","year":"2021","journal-title":"Cartilage"},{"key":"2024082721105793000_14.6.e081343.53","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g6870","article-title":"Discontinuation and non-publication of surgical randomised controlled trials: observational study","volume":"349","author":"Chapman","year":"2014","journal-title":"BMJ"},{"key":"2024082721105793000_14.6.e081343.54","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-018-2825-y","article-title":"Adherence to the International committee of medical Journal editors\u2019 (ICMJE) prospective registration policy and implications for outcome integrity: A cross-sectional analysis of trials published in high-impact specialty society journals","volume":"19","author":"Gopal","year":"2018","journal-title":"Trials"},{"key":"2024082721105793000_14.6.e081343.55","unstructured":"Sense about Science . What is Alltrials? n.d. Available: https:\/\/senseaboutscience.org\/alltrials"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-081343","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:14:36Z","timestamp":1724804076000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-081343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":55,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6,25]]},"published-print":{"date-parts":[[2024,6]]}},"alternative-id":["10.1136\/bmjopen-2023-081343"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-081343","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6]]}}}